Vasopressors and the Kidney
- 27 February 2002
- journal article
- review article
- Published by S. Karger AG in Blood Purification
- Vol. 20 (3) , 243-251
- https://doi.org/10.1159/000047016
Abstract
The changes in renal perfusion induced by vasopressors depend on their effects on systemic hemodynamics and renal vascular resistance. Both effects are largely influenced by the patient’s underlying condition such as myocardial contractility and vascular responsiveness. A beneficial effect can be expected if mean arterial pressure increases without decreasing cardiac output and if the effect on renal vascular resistance is less pronounced than on systemic vascular resistance. Acute renal failure is associated with loss of renal autoregulation and sepsis is associated with blood pressures below the autoregulatory threshold. Both conditions might therefore benefit from the administration of vasopressors. Many experimental and clinical data indeed suggest a beneficial effect of norepinephrine on the urine output in sepsis. A beneficial effect on renal function (glomerular filtration) is a less consistent finding suggesting that pressure diuresis might be partially responsible for the pressor-induced diuresis. Administration of vasopressors to patients with oliguria should be considered in fluid-resuscitated patients with distributive shock. Whether other vasopressors offer advantages over norepinephrine requires further investigation.Keywords
This publication has 8 references indexed in Scilit:
- Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trialThe Lancet, 2000
- Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shockThe Annals of Thoracic Surgery, 2000
- Effects of nitric oxide blockade and cyclosporin A on cardiovascular and renal function in normal manJournal Of Hypertension, 1999
- Role of nitric oxide in lipopolysaccharide-induced oxidant stress in the rat kidneyBiochemical Pharmacology, 1999
- Low‐dose vasopressin restores diuresis both in patients with hepatorenal syndrome and in anuric patients with end‐stage heart failureJournal of Internal Medicine, 1999
- Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndromeJournal of Hepatology, 1998
- Systematic review: The use of diuretics and dopamine in acute renal failure: a systematic review of the evidenceCritical Care, 1997
- The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsisPublished by American Medical Association (AMA) ,1994